Sonnet BioTherapeutics Holdings, Inc. SONN
1.26 0.00 (+0.00%)
At closeDec 2, 2025, 4:00 PM EST
1.26 Day range 3.23
1.42 52-week range 18.72
- YTD
- -13.70%
- 1 year
- -51.72%
Revenue & Expenses
Latest period ending Sep 30, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|
| 18.63K | 147.81K | 349.94K | 483.63K | 0 | |
| 18.63K | 147.81K | 349.94K | 483.63K | 0 | |
| -11.85M | -18.79M | -29.67M | -25.09M | -24.24M | |
| -7.44M | -18.83M | -29.72M | -24.98M | -24.27M | |
| -11.35 | -145.13 | -1,204.00 | -2,508.00 | -17,149.00 |
Balance sheet
| Fiscal year | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|
| 149.46K | 2.27M | 3.05M | 27.62M | 7.35M | |
| 2.77M | 5.43M | 5.83M | 28.99M | 7.99M | |
| 3.26M | 5.66M | 8.37M | 6.73M | 4.97M | |
| 130.86K | 203.91K | 255.99K | 125.88K | 353.25K | |
| -485.74K | -225.98K | -2.54M | 22.26M | 3.02M |
Cash flow
| Fiscal year | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|
| -8.61M | -21.34M | -27.77M | -22.55M | -15.61M | |
| -12.00K | -443.25K | -810.23K | -3.62K | -76.18K | |
| 6.49M | 21.01M | 4.01M | 42.83M | 23.01M | |
| -2.12M | -778.62K | -24.57M | 20.27M | 7.31M |